The efficacy of radiotherapy in the treatment of intraocular metastases

The British Journal of Radiology
E MinatelG Bassignano

Abstract

From January 1980 to May 1991, 28 patients with intraocular metastases were seen at our Institute. Three presented with bilateral metastases and two developed contralateral involvement. Out of the 33 ocular metastases 27 were managed by radiotherapy. The most common primary tumour sites were breast (18/28 patients) and lung (3/28). 22 patients were treated with an 8 MV linear accelerator, using a 4 x 4 cm anterior direct field. The median dose was 40 Gy/20 fractions (range 28 Gy/14 fractions to 50 Gy/25 fractions). Of the 27 treatments reported, 16 resulted in a complete response (59%), six in a partial response (22%) and five resulted in no change (19%). Complete and partial responses lasted for a median time of 13 months (range of 3-89+ months). The median survival time from the start of ocular treatment was 13 months. The aim of radiation treatment is either to prevent or to postpone the visual loss caused by intraocular metastases.

References

Jul 1, 1979·Ophthalmology·R F Stephens, J A Shields
Feb 1, 1988·The British Journal of Radiology·W Dobrowsky
Oct 1, 1974·Archives of Ophthalmology·A P Ferry, R L Font
Apr 1, 1972·Cancer·M M OrensteinJ J Stein
Jun 1, 1971·Archives of Ophthalmology·R S Bloch, S Gartner
Feb 1, 1982·Cancer·L W BradyJ L Day
Jan 1, 1982·American Journal of Ophthalmology·A D LetsonR A Bruce

❮ Previous
Next ❯

Citations

Jan 22, 2009·International Seminars in Surgical Oncology : ISSO·Nikolaos ThomakosRaj Naik
Nov 13, 2004·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·M MartinS Dithmar
Dec 20, 2005·Seminars in Ophthalmology·R V Paul Chan, Lucy H Young
Mar 25, 2008·Optometry : Journal of the American Optometric Association·Jeff Miller
Nov 7, 2007·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Hülya G Soysal
Feb 5, 2005·Ophthalmology·Efthymia K TsinaEvangelos S Gragoudas
May 1, 1997·Current Problems in Cancer·D Hoegler
Dec 3, 2014·International Journal of Radiation Oncology, Biology, Physics·Sophia C KamranHelen A Shih
May 7, 2002·American Journal of Ophthalmology·Jyotirmay BiswasMahesh P Shanmugam
Sep 1, 2007·Clinical & Experimental Ophthalmology·Gowri L KanthanR Max Conway
Mar 12, 2008·Medical Oncology·Tulay SimsekNilufer Berker
Apr 13, 2000·Cancer Control : Journal of the Moffitt Cancer Center·W Small

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie. Albrecht Von Graefe's Archive for Clinical and Experimental Ophthalmology
E M RöttingerG Meyer-Schwickerath
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
A RossetR O Mirimanoff
© 2021 Meta ULC. All rights reserved